Hudson Bay Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
2025
Q3
$143K Sell
2025
Q2
$4.96M Buy
2025
Q1
$3.13M Buy
2024
Q4
$406K Buy
2024
Q3
Sell
2024
Q2
$660K Buy
2024
Q1
Sell
2023
Q4
$906K Buy
2023
Q3
Sell
2023
Q2
$3.06M Buy